Insider Shareholders with Direct Ownership of Vertex Pharmaceuticals Inc (VRTX)
This section provides a comprehensive overview of the insiders with direct ownership of Vertex Pharmaceuticals Inc (VRTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
VERTEX PHARMACEUTICALS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Reshma Kewalramani
CEO & President |
340,338 | 261,467 | 105,915 $50.8 Million | 41 |
Feb 26, 2025
Reduced 11.73%
|
|
Amit Sachdev
EVP Chief Patient & Ext Af Off |
134,328 | 105,651 | 68,490 $32.9 Million | 39 |
Feb 26, 2025
Reduced 5.13%
|
|
Stuart A Arbuckle
EVP, COO |
210,610 | 183,257 | 62,935 $30.2 Million | 56 |
Feb 26, 2025
Reduced 10.1%
|
|
Ourania Tatsis
EVP, Chief Reg. & Quality Off. |
120,539 | 75,134 | 58,539 $28.1 Million | 45 |
Feb 27, 2025
Reduced 0.9%
|
|
Charles F Wagner Jr
EVP & Chief Financial Officer |
123,964 | 85,579 | 54,969 $26.4 Million | 39 |
Feb 26, 2025
Reduced 8.28%
|
|
Bruce I Sachs
Director |
87,368 | 58,578 | 40,000 $19.2 Million | 15 |
Aug 01, 2024
Reduced 11.69%
|
|
David Altshuler
EVP, Chief Scientific Officer |
169,011 | 165,375 | 32,974 $15.8 Million | 59 |
Feb 27, 2025
Reduced 3.71%
|
|
Carmen Bozic
EVP and CMO |
115,735 | 97,057 | 32,669 $15.7 Million | 38 |
Feb 26, 2025
Reduced 13.19%
|
|
Bastiano Sanna
EVP, Cell & Genetic Therapies |
73,933 | 63,316 | 32,038 $15.4 Million | 43 |
May 08, 2023
Reduced 8.17%
|
|
Michael Parini
EVP, Chief Adm, Leg & BD Off |
35,049 | 31,141 | 30,837 $14.8 Million | 13 |
Feb 25, 2021
Reduced 1.13%
|
|
Jeffrey M Leiden
Executive Chairman |
348,871 | 327,268 | 24,026 $11.5 Million | 36 |
Feb 14, 2025
Reduced 20.16%
|
|
Edward Morrow Atkinson Iii
EVP, Chief Technical Ops. Off. |
41,202 | 35,729 | 19,352 $9.28 Million | 21 |
Feb 27, 2025
Reduced 12.04%
|
|
Jonathan Biller
EVP and Chief Legal Officer |
31,805 | 14,199 | 17,606 $8.45 Million | 16 |
Feb 18, 2025
Reduced 8.6%
|
|
Paul M Silva
SVP & Chief Accounting Officer |
11,080 | 16,128 | 9,884 $4.74 Million | 9 |
Mar 01, 2021
Reduced 2.28%
|
|
Joy Liu
SVP, General Counsel |
8,941 | 12,975 | 9,605 $4.61 Million | 11 |
Aug 15, 2022
Reduced 3.03%
|
|
Kristen Ambrose
SVP & Chief Accounting Officer |
19,385 | 12,934 | 7,845 $3.76 Million | 25 |
Feb 26, 2025
Reduced 13.66%
|
|
Terrence C Kearney
Director |
10,725 | 10,000 | 6,536 $3.14 Million | 3 |
Aug 10, 2023
Reduced 60.47%
|
|
Alan M Garber
Director |
584 | 0 | 6,474 $3.11 Million | 1 |
May 01, 2023
Added 8.27%
|
|
Lloyd Carney
Director |
5,460 | 2,700 | 6,319 $3.03 Million | 5 |
May 01, 2024
Added 13.67%
|
|
Sangeeta N. Bhatia
Director |
18,034 | 19,294 | 4,435 $2.13 Million | 22 |
Aug 30, 2024
Reduced 12.71%
|
|
Suketu Upadhyay
Director |
3,727 | 1,168 | 2,559 $1.23 Million | 4 |
May 01, 2024
Reduced 31.34%
|
|
Diana Mckenzie
Director |
5,460 | 4,459 | 2,436 $1.17 Million | 7 |
May 01, 2024
Reduced 32.41%
|
|
Yuchun Lee
Director |
40,000 | 40,000 | 1,875 $899,606 | 34 |
Jan 27, 2023
Reduced 4.09%
|
|
Nancy Thornberry
Director |
1,637 | 0 | 1,637 $785,416 | 2 |
May 01, 2024
Added 23.43%
|
|
Michel Lagarde
Director |
1,132 | 0 | 1,132 $543,122 | 1 |
Oct 05, 2023
Added 50.0%
|
|
Jennifer Schneider
Director |
922 | 0 | 922 $442,366 | 1 |
May 15, 2024
Added 50.0%
|
|
Margaret G Mcglynn
Director |
15,921 | 16,620 | 178 $85,402 | 9 |
May 01, 2022
Reduced 83.8%
|